Catalyst
Slingshot members are tracking this event:
PTCT Acquires Duchenne Muscular Dystrophy Drug (DMD) Emflaza (Deflazacort) from Marathon Pharmaceuticals
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTCT |
|
|
Marathon Pharmaceuticals |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 16, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Duchenne Muscular Dystrophy, Dmd, Emflaza, Deflazacort
